- €138.74m
- €93.84m
- €1.91bn
Oriola: Slides as pandemic hampers drugs distribution in Q2
Brief: Oriola Q2 Adjusted EBIT Swings To Loss EUR -0.3 Mln
Brief: Oriola Makes Additional Investment In Swedish Doktor.se
Digital healthcare provider Doktor.se raises $49.8 mln for expansion
Brief: Oriola Starts Maintaining Dispensary In Sweden
Oriola: Increased pharmaceuticals demand in Q1 boosts shares
Brief: Q1 Oriola Net Sales at EUR 459.8 Million
Brief: Oriola Q4 Adjusted EBIT Falls To EUR 2.1 Million
Brief: Oriola Proposes Panu Routila As New Chairman
Finland's Oriola says failed IT change caused 2017 distribution problems (updated)
Finnish watchdog reports shortcomings in Oriola's 2017 drugs distribution - STT news agency
Brief: Oriola Oyj Says Inventory And Intangible Assets Write Down Affecting Co's Q4 Result Significantly
Brief: Oriola And MSD Sign Distribution Contract For Finnish Market
Brief: Oriola Q3 Adjusted Operating Profit Down At EUR 9.8 Mln
Brief: Oriola Signs Distribution Agreement With MSD For Swedish Market
Brief: Oriola To Reduce 83 Positions As A Result Of Restructuring
Brief: Oriola And Orion Renew Their Distribution Agreement
Brief: Oriola Q2 Adjusted EBIT Down At EUR 6.4 Million
Oriola: Slips after gloomier outlook for 2019